Track the Kintor Pharmaceutical Ltd. - B share price and the full insider trade history of the company, a publicly traded company based in Hong Kong. Shares are listed on the HK market, under the oversight of HKEX. Operating in the Health Care sector, Kintor Pharmaceutical Ltd. - B has published 21 insider filings. Market capitalisation: €773.7m. The latest transaction was filed on 21 July 2026 (Purchase). Among the most active insiders: Tong Youzhi. The full history is accessible without an account.
21
Insider Decl.
n/a
Thresholds
€7m
19 ops.
Buy Volume
n/a
n/a
Sell Volume
28Σ signal
Buys €7mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,046 of 29,064 companies
13.4
score / 100
Value
9
Quality
17
FCF yld-21%
Earn yld-25%
EV/EBITDA·
ROE-118%
Gross mgn25%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Kintor Pharmaceutical Ltd. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos innovadores para enfermedades graves. Cotiza en la Bolsa de Valores de Hong Kong.